During the October 1 episode of Mad Money, Jim Cramer discussed Amgen Inc. (NASDAQ:AMGN) while reviewing the Dow Jones Industrial Average’s third-quarter performance.
Keep Reading →
October 7 - Hedge Funds, News
Pfizer Inc. (NYSE:PFE) looks cheap based on its forward P/E, but its earnings outlook helps explain the discount.
Keep Reading →
October 7 - News
Johnson & Johnson (NYSE:JNJ) is starting to look less like a defensive healthcare giant and more like a growth story.
Keep Reading →
October 7 - Hedge Funds, News
Obesity drugs, pipeline investment, and manufacturing capacity are reshaping the pharmaceutical industry's growth equation.
Keep Reading →
October 3 - Hedge Funds, News
Johnson & Johnson (NYSE:JNJ) closed at $264.74 on September 30, almost 43% higher than a year ago and within a few percent of its record.
Keep Reading →
September 30 - Hedge Funds, News
On September 25, Johnson & Johnson (NYSE:JNJ) announced top-line findings from its Phase 4 STAR study evaluating Tremfya (guselkumab) in biologic-naïve adults with active psoriatic...
Keep Reading →
September 28 - Hedge Funds, News
Johnson & Johnson's (NYSE:JNJ) $14.6 billion acquisition of Intra-Cellular Therapies has gained another potential growth avenue after Caplyta met the main goal of a late-stage...
Keep Reading →
September 28 - Hedge Funds, News
Guggenheim has assumed coverage of Nanobiotix S.A.
Keep Reading →
September 28 - Hedge Funds, News
Healthcare has rarely been short of investment opportunities, but deciding where to look has become more complicated.
Keep Reading →
September 28 - Hedge Funds, News
Gilead Sciences, Inc. (NASDAQ:GILD) and Johnson & Johnson (NYSE:JNJ) offer investors two very different versions of pharmaceutical growth.
Keep Reading →
September 27 - Hedge Funds, News
Johnson & Johnson (NYSE:JNJ) already has RYBREVANT approved across multiple EGFR-mutated advanced lung cancer settings.
Keep Reading →
September 24 - Hedge Funds, News
Contineum Therapeutics, Inc.
Keep Reading →
September 24 - Hedge Funds, News
It was reported on September 11 that Apollo Global Management, Inc.
Keep Reading →
September 24 - Hedge Funds, News
The Federal Reserve raised interest rates by 25 basis points on September 16, taking its target range to 3.75%-4%. It was the first rate hike since 2023.
Keep Reading →
September 22 - Dividend Stocks, Hedge Funds, News
Apollo Global Management, Inc.
Keep Reading →
September 15 - Hedge Funds, News
Johnson & Johnson (NYSE:JNJ) has secured Chinese approval for Icotyde, its once-daily oral treatment for moderate-to-severe plaque psoriasis.
Keep Reading →
September 9 - Hedge Funds, News
Pharmaceutical giant Johnson & Johnson (NYSE:JNJ) is one of Jim Cramer's favorite stocks in the sector.
Keep Reading →
August 28 - News
Patent expirations are forcing Pfizer Inc.
Keep Reading →
August 23 - Hedge Funds, News
Johnson & Johnson (NYSE:JNJ) has proposed a whopping $5.5 billion settlement to resolve tens of thousands of lawsuits that allege its baby powder and other talc products cause...
Keep Reading →
August 23 - Hedge Funds, News
Healthcare investors looking for long-term growth don't always have to choose between fast-growing companies and defensive businesses.
Keep Reading →
August 23 - Hedge Funds, News
Johnson & Johnson (NYSE:JNJ) continues to stand out as a dividend stock for investors who value dependable income and a long track record of growth.
Keep Reading →
August 18 - Dividend Stocks, Hedge Funds, News
Johnson & Johnson (NYSE:JNJ) delivered another strong quarter in fiscal Q2 2026, with reported sales increasing 6.6% year over year to $25.31 billion and surpassing analysts’ ...
Keep Reading →
August 10 - Hedge Funds, News
Johnson & Johnson (NYSE:JNJ) delivered strong fiscal Q2 2026 results, with sales for the quarter growing nearly 7% to $25.31 billion, above analysts' average estimate of about...
Keep Reading →
August 10 - Hedge Funds, News
During the August 6 episode of CNBC’s Mad Money, Jim Cramer pointed to a growing sector rotation as portfolio managers look for innovation outside the mega-cap technology space...
Keep Reading →
August 10 - News
Johnson & Johnson (NYSE:JNJ) has officially entered the U.S.
Keep Reading →
August 10 - Hedge Funds, News
Jim Cramer celebrated a dramatic pivot in market sentiment surrounding Johnson & Johnson (NYSE:JNJ) during Mad Money’s July 23 episode.
Keep Reading →
August 3 - News
Johnson & Johnson (NYSE:JNJ) delivered strong fiscal Q2 2026 results, with sales for the quarter growing nearly 7% to $25.31 billion, above analysts' average estimate of about...
Keep Reading →
July 27 - Hedge Funds, News
Healthcare giant Johnson & Johnson (NYSE:JNJ) is one of Jim Cramer's top healthcare stocks even though the shares have been lackluster.
Keep Reading →
July 25 - News
In this article, we will look at Jim Cramer’s stock calls on Mad Money, as he highlighted the AI opportunities in neoclouds.
Keep Reading →
July 8 - Hedge Funds, News
In this article, we will discuss: Jim Cramer's Biggest Winners to Buy: Top 20 AI & Other Stocks He Got Right in 2026.
Keep Reading →
July 4 - News
In this article, we will highlight Billionaire Cliff Asness’ Top 10 Healthcare Stock Picks.
Keep Reading →
June 30 - Hedge Funds, News
In this article, we will discuss the 10 Best Dividend Aristocrat Stocks To Buy Now.
Keep Reading →
June 30 - Dividend Stocks, Hedge Funds, News
In this article, we will discuss: 10 Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds.
Keep Reading →
June 27 - Hedge Funds, News
In this article, we will take a look at the 10 Best Dividend Stocks to Buy for Passive Income.
Keep Reading →
June 26 - Dividend Stocks, Hedge Funds, News
In this article, we will discuss the 10 Best Stocks For Beginners to Buy Now.
Keep Reading →
June 25 - Hedge Funds, News
In this article, we present the Top 10 Stock Picks of 2026 from Kevin O'Leary's Portfolio.
Keep Reading →
June 19 - Hedge Funds, News
In this article, we will take a look at the Dividend Stock Portfolio: Top 10 Stocks to Buy According to Reddit.
Keep Reading →
June 17 - Dividend Stocks, Hedge Funds, News
In this article, we are going to discuss the 12 most profitable American stocks to buy in 2026.
Keep Reading →
June 17 - Hedge Funds, News
In this article, we will look at the stocks Jim Cramer commented on, as he explained that tech stocks cannot be trusted to lead anymore.
Keep Reading →
June 11 - Hedge Funds, News
In this article, we will look at the 7 Best Longevity Stocks to Buy Now.
Keep Reading →
June 11 - Hedge Funds, News
In this article, we will discuss: Jim Cramer Didn't Hold Back On SpaceX's IPO & Discussed These 12 Stocks.
Keep Reading →
June 11 - News
In this article, we will look at the stocks Jim Cramer discussed on Mad Money, along with the recent sell-off in the market.
Keep Reading →
June 9 - Hedge Funds, News
In this article, we will discuss the 10 Cheap Robotics Stocks to Buy Right Now.
Keep Reading →
June 6 - Hedge Funds, News
In this article, we will look at Jim Cramer’s stock calls on Mad Money, as he highlighted several opportunities in out-of-favor sectors.
Keep Reading →
June 4 - Hedge Funds, News
In this article, we will take a look at the 15 Best Dividend Paying Stocks to Buy Right Now.
Keep Reading →
May 31 - Dividend Stocks, Hedge Funds, News
Johnson & Johnson (NYSE:JNJ) is one of the best medical stocks to invest in according to billionaires.
Keep Reading →
May 25 - News
In this article, we will look at the 12 Best Medical Stocks to Invest In According to Billionaires.
Keep Reading →
May 24 - Hedge Funds, News
In this article, we will discuss the 10 Best Low Risk Stocks to Buy in 2026. On May 13, Sébastien Page of T.
Keep Reading →
May 22 - Hedge Funds, News
Hedge Fund Resource Center 
